Narayana Hrudayalaya Share Price

Narayana Hrudayalaya Limited, with its corporate operations in Bengaluru, functions as a private healthcare service provider in India . The company provides diverse healthcare services through its hospitals, cardiac centres, and multi-specialty facilities. Narayana Hrudayalaya has a substantial reach with hospitals spread across multiple states in India, including Karnataka, West Bengal, Gujarat, Rajasthan, and Uttar Pradesh. The company also has a presence in the Cayman Islands through its international hospital.

Narayana Hrudayalaya share price on NSE and BSE signifies how market participants react to the company’s operational performance and the overall developments in the healthcare sector. The company’s financial health depends on patient volumes, hospital occupancy rates, average revenue per bed, and the performance of its cardiac and oncology segments. Narayana Hrudayalaya stock price is influenced by various factors such as earnings reports, changes in medical tourism trends, and regulatory policies affecting private healthcare. In the longer run, strategies such as bed capacity expansion, new hospital openings, and digital health initiatives affect the stock market sentiments. All these factors need monitoring to have an idea about the company’s stock price movements.

Narayana Hrudayalaya live share price provides real-time information about the last price traded, bid and ask prices, and volume traded. These indicators represent market activity and liquidity, reflecting investor response to corporate announcements, economic conditions, and sector news. Constant monitoring of the Narayana Hrudayalaya stock price movements helps in observing short term price volatility and shows how a stock moves relative to the broader healthcare index. Furthermore, monitoring Narayana Hrudayalaya live price helps investors understand real-time market sentiment, price fluctuations, and trading behaviour. It allows them to evaluate short-term performance and respond to news, quarterly results, or sector trends that may influence the company’s valuation.

1. Company Background

Narayana Hrudayalaya Limited (operating under the brand Narayana Health) was incorporated in 2000 and founded by Devi Prasad Shetty. The company began with a cardiac hospital in Bengaluru, Karnataka, and has since developed into a multi-specialty healthcare provider. Headquartered in Bengaluru, the company operates a network of hospitals, heart centres, and primary care facilities across India and internationally. Its core focus includes affordable healthcare delivery, particularly in cardiac care, along with expansion into other specialties such as oncology, nephrology, and organ transplants. The company also operates internationally through its facilities in the Cayman Islands. It is listed on Indian stock exchanges and serves both domestic and international patients through its hospital network.

2. Company Product Lines

• Cardiac Sciences

• • Adult and paediatric cardiology

• • Cardiothoracic and vascular surgery

• Oncology and Renal Sciences

• • Medical, surgical, and radiation oncology

• • Nephrology, dialysis, and kidney transplant services

• Multi-Specialty Services

• • Orthopaedics

• • Neurosciences

• • Gastroenterology

• • Organ transplant programs

• Primary Care and Diagnostics

• • Network of clinics providing outpatient services

• • Diagnostic services including laboratory and imaging

• Other Healthcare Services

• • Pharmacy and support services within hospital network

3. Company Revenue Model

• Inpatient Services

• • Revenue from surgeries, hospital stays, and critical care treatments

• Outpatient Services

• • Income from consultations, diagnostics, and follow-up treatments

• Pharmacy and Diagnostics

• • Revenue from in-hospital pharmacy and diagnostic services

• International Operations

• • Revenue from overseas facilities, including Cayman Islands operations

• Other Healthcare Services

• • Ancillary income from managed services and healthcare-related offerings

Revenue is influenced by patient volumes, case mix, occupancy rates, and expansion of specialty services.

4. Geographic Presence

• Headquarters / Registered Office

• • Bengaluru, Karnataka, India

• Domestic Locations (India)

• • Hospitals and healthcare facilities across multiple cities including:

• • Bengaluru, Karnataka

• • Mysuru, Karnataka

• • Davangere, Karnataka

• • Kolkata, West Bengal

• • Howrah, West Bengal

• • Jaipur, Rajasthan

• • Ahmedabad, Gujarat

• • Raipur, Chhattisgarh

• • Gurugram, Haryana

• • Jamshedpur, Jharkhand

• • Mumbai, Maharashtra

• • Delhi

• International Presence

• • Cayman Islands (Health City Cayman Islands facilities)

5. Key Milestones

• 2000: Incorporation and establishment of first cardiac hospital in Bengaluru
• 2001–2003: Expansion of cardiac care services and participation in healthcare access initiatives such as the Yeshasvini scheme
• 2008: Establishment of major hospital facility in Kolkata
• 2014: Commencement of international operations in the Cayman Islands
• 2016: Listing on NSE and BSE
• 2010s–2020s: Expansion into multi-specialty healthcare including oncology, nephrology, and organ transplantation
• Recent Years: Continued expansion of hospital network and focus on digital healthcare initiatives

6. Industry Perspective

The healthcare sector is driven by rising demand for hospital services due to population growth, increasing incidence of chronic diseases, and higher healthcare awareness. Demand for specialized care such as cardiac treatment, oncology, and organ transplants continues to grow. The sector is also influenced by factors such as affordability, regulatory policies, and insurance penetration.

Digital technologies, including electronic medical records and telemedicine, are being adopted to improve efficiency and patient care. Government initiatives to expand healthcare access and insurance coverage support long-term sector growth. Hospital operators focus on capacity expansion, clinical quality, and cost efficiency to remain competitive in a growing healthcare market. 

Narayana Hrudayalaya Stock Market Presence: Listings & Index Representation

Narayana Hrudayalaya Limited is listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). Narayana Hrudayalaya share price is available for trading on the NSE under the symbol NH and on the BSE with the scrip code 539551 . The company’s market presence is primarily within the mid-cap segment of the market . Due to its size and sector focus, Narayana Hrudayalaya stock price is generally tracked by investors interested in the healthcare and hospital services industry.

Narayana Hrudayalaya is part of several broad-based and sector-specific stock market indices, reflecting its position as a mid-cap healthcare company in India. Narayana Hrudayalaya share price is a constituent of wider market indices such as the Nifty 500, which tracks a large universe of listed companies across sectors . The company is also included in the Nifty Smallcap 100 and Nifty Smallcap 250 indices . In addition, the company is included in multiple BSE indices, including the BSE 500 and BSE Healthcare index, as well as broader composite indices like the BSE AllCap, which capture companies across large, mid, and small-cap segments.

Narayana Hrudayalaya Stock Performance and Share Price History

Narayana Hrudayalaya share price on NSE reflects its status as a private multi-specialty healthcare provider in India. Performance gets driven by hospital occupancy rates, average revenue per bed, patient volumes across cardiac and oncology services, and the company’s ability to manage operational costs effectively. Investors compare Narayana Hrudayalaya share price today with other hospital chains to gauge relative performance within the sector.

These underlying factors often appear through real market movements across different periods. Broader sector strength has played a role in supporting Narayana Hrudayalaya share price. In addition to operational and sector-led factors, corporate actions such as dividend announcements can also have a significant impact on Narayana Hrudayalaya share price movements in the short term. The company has paid dividends to shareholders in recent years, showing its ability to reward them . This shows how corporate actions can trigger short-term swings, even within a regulated healthcare framework influenced by medical inflation and regulatory policies.

While short-term movements reflect events and announcements, longer-term valuation trends become visible through Narayana Hrudayalaya share price 52-week high and low, providing context beyond daily or weekly changes . Highs indicate strong patient demand and stable margins, while lows align with market corrections or sector volatility . These levels capture the impacts of healthcare policies, medical tourism trends, and earnings visibility, providing context for the stock’s historical performance.

Narayana Hrudayalaya stock performance reflects the trading behaviour of a mid-cap private healthcare company operating within India’s regulated healthcare system. The company’s diversified healthcare portfolio across cardiac sciences, neuro sciences, orthopaedics, and cancer care has shaped its Narayana Hrudayalaya share price history. Over time, the stock has shown long-term wealth creation, marked by periods of gains and phases of consolidation . The company completed its initial public offering in December 2015, getting its securities listed on the BSE and NSE on 6 January 2016 .

Narayana Hrudayalaya stock performance over time has closely followed India’s healthcare demand and policy cycles. For instance, the company’s focus on affordable cardiac care and expansion into new geographies has been viewed favourably. Over longer investment horizons, the stock has delivered meaningful returns, including gains over three years and five years . These returns highlight consistent growth aligned with expanding healthcare access and increasing medical spending across the Indian economy. The stock has shown a compound annual growth rate of over twenty eight percent over three years .

Despite COVID-19 disruptions, Narayana Hrudayalaya shares showed resilience. While the broader healthcare sector faced challenges with elective surgeries and outpatient volumes, the company’s focus on essential medical services helped the stock retain value. Prudent management and strong brand reputation across its hospital network kept shares stable amid the pandemic’s challenges and market volatility. The company’s hospitals continued to serve patients, and its telemedicine initiatives helped maintain operations during lockdowns.

Narayana Hrudayalaya share price has seen decreases due to several recurring reasons. A decline in hospital occupancy rates or a drop in average revenue per patient directly impacts profitability and leads to selling pressure. Changes in government policy, such as price controls on medical procedures or drugs, can also cause the stock to fall. Furthermore, any increase in operational costs like salaries for medical staff or procurement costs for medicines without a matching rise in patient revenues squeezes the company’s margins, making the stock less attractive. Periods of economic slowdown that affect discretionary healthcare spending raise concerns about patient volumes, leading to a drop in Narayana Hrudayalaya share price. The stock is also sensitive to regulatory changes in medical insurance; if insurance reimbursement rates are reduced, it can lead to a decrease in Narayana Hrudayalaya stock price as investors adjust expectations for future revenue growth. Broader market sell-offs in mid-cap stocks also pull the price down, regardless of the company’s individual performance. A decrease in footfall at hospitals or lower occupancy in newly opened facilities directly hurts the company’s revenue, resulting in a lower valuation for Narayana Hrudayalaya share price.

Narayana Hrudayalaya Investor Relevance and Role in Portfolio

Narayana Hrudayalaya is a holding in healthcare and mid-cap portfolios, offering exposure to multi-specialty hospital services, cardiac care, and oncology treatment. Inclusion in healthcare indices underscores its importance in India’s private healthcare delivery space. The company’s diversified healthcare model, strong brand presence in South and East India, and growing national footprint make it a consideration for long-term allocations.

Narayana Hrudayalaya equity is held by a broad mix of domestic and international institutional investors, reflecting its standing in India’s healthcare sector. Promoters hold approximately sixty three percent of the company . Prominent mutual fund holders include Mirae Asset Mutual Fund, Nippon Life India Asset Management, and Axis Asset Management Company . Other institutional investors include The Vanguard Group, BlackRock, Inc., Franklin Resources, and the Government Pension Fund Global . This broad investor base with institutional participation underscores the company’s role as a holding in both domestic and global portfolios focused on healthcare delivery services.

Beyond fundamentals and ownership, Narayana Hrudayalaya share price is monitored by market participants. The stock does not trade in the futures and options segment on the NSE . Market participants still watch the stock closely to gauge sentiment around quarterly results and policy announcements. The company’s operating performance and expansion plans remain key focus areas for investors.

Technical indicators such as RSI, MACD, and MFI provide additional insight into short-term momentum shifts in the company’s stock price. While these indicators are primarily used for near-term trading decisions, they also help investors and portfolio managers understand broader market sentiment and anticipate potential volatility, especially around key events or announcements.

Narayana Hrudayalaya stock price has exhibited certain volatility patterns. Narayana Hrudayalaya beta has generally remained moderate, reflecting its position as a mid-cap healthcare stock with strong institutional participation and relatively stable business fundamentals. Over shorter timeframes, the stock has shown relatively higher sensitivity to market movements, indicating short-term volatility. During the three-month period, this sensitivity appears more balanced, suggesting a closer alignment with broader market trends. Across longer durations, the beta trends lower, indicating reduced volatility and a weaker correlation with overall market fluctuations. This shift suggests that over time, the stock behaves more defensively, which is typical for companies in the healthcare services sector. Overall, these variations across different timeframes highlight that while Narayana Hrudayalaya may experience short-term fluctuations, its longer-term volatility remains relatively stable, reinforcing its characteristics as a fundamentally steady healthcare stock.

Narayana Hrudayalaya Sectoral Relevance and Peer Positioning

Narayana Hrudayalaya sector relevance stems from its scale in multi-specialty hospital operations across India, its network of cardiac centres, and its brand recognition in affordable healthcare. Peer comparisons with Apollo Hospitals Enterprise, Max Healthcare Institute, Aster DM Healthcare, Fortis Healthcare, Global Health, and Dr. Lal Pathlabs focus on bed capacity, occupancy rates, average revenue per bed, and geographical presence rather than short-term stock moves . These benchmarks help investors assess operational scale, efficiency, and regulatory adherence. Institutional tracking of medical inflation, health insurance penetration, and medical tourism flows further highlights Narayana Hrudayalaya positioning within India’s broader healthcare delivery market.

Narayana Hrudayalaya market cap history shows the company’s position within the healthcare sector. Earlier in its history, the market capitalization remained at more moderate levels as the company operated primarily as a cardiac care provider. The shift toward multi-specialty services and expansion into new geographies led to a re-evaluation by the market. This transition from a cardiac-focused hospital chain to a diversified healthcare provider has been a key factor in how the company’s overall valuation has evolved over time. The company currently maintains a market capitalization in the mid-cap range .

Narayana Hrudayalaya earnings history demonstrates the impact of its strategic business decisions. In earlier periods, earnings reflected the growth trajectory of the hospital business with expansion-related costs. As the company matured its existing facilities and added new hospitals, earnings patterns showed improvement. The company’s focus on affordable healthcare and operational efficiency contributed to changes in its earnings profile over the years. The company reported total revenue growth in recent financial years, supported by increased patient volumes and higher occupancy rates.

Narayana Hrudayalaya EPS provides insight into its operational performance and income generation from hospital services, outpatient care, and diagnostics. Over the years, earnings per share have shown variation in line with the company’s business cycle and industry conditions. The expansion into new geographies and addition of super-specialty services have influenced the EPS trajectory. Quarterly performance reflects the ongoing earnings from both domestic and international operations, with the cardiac sciences division contributing significantly to the overall per-share earnings picture.

Narayana Hrudayalaya P/E ratio reflects how investors perceive the company’s earnings relative to its business model. The company’s price-to-earnings ratio has been at levels that indicate the valuation the market assigns to the company’s earnings . This ratio has moved in response to how investors view the company’s prospects in areas like new hospital openings and international expansion. These changes highlight how market sentiment has evolved alongside the company’s business transformation and growth strategy.

Summary

Narayana Hrudayalaya Limited operates multi-specialty hospitals and cardiac centres providing healthcare services across India and internationally. Narayana Hrudayalaya share price on the NSE and BSE reflects trading activity within the private healthcare delivery industry. The company has a notable presence in both domestic and international markets. Narayana Hrudayalaya stock price is influenced by patient volumes, occupancy rates, regulatory changes, and broader economic factors. The company’s focus on affordable multi-specialty care remains a key aspect of its business profile.